Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Kreshnik Zejnullahu | Researchclopedia

Back to researchers

Kreshnik Zejnullahu

University of California, San Francisco

68

Works

9,513

Citations

13

h-index

13

i10-index

Research Topics

Lung Cancer Treatments and Mutations HER2/EGFR in Cancer Research Cytokine Signaling Pathways and Interactions

Affiliations

Brigham and Women's Hospital2008–2012

National Institutes of Health2012–2012

Howard Hughes Medical Institute2012–2012

Harvard University2007–2008

University of Massachusetts Chan Medical School2011–2011

Top Works

<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

Jeffrey A. Engelman,Kreshnik Zejnullahu,et al.

20074,440 citations

Cancer therapeutics and mechanisms

Lung Cancer Research Studies

Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC

Alexa B. Turke,Kreshnik Zejnullahu,et al.

20101,055 citations

<i>EML4-ALK</i> Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer

Jussi Koivunen,Craig H. Mermel,et al.

2008975 citations

PF00299804, an Irreversible Pan-ERBB Inhibitor, Is Effective in Lung Cancer Models with <i>EGFR</i> and <i>ERBB2</i> Mutations that Are Resistant to Gefitinib

Jeffrey A. Engelman,Kreshnik Zejnullahu,et al.

2007717 citations

Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab

Kimio Yonesaka,Kreshnik Zejnullahu,et al.

2011662 citations

Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer

J. A. Engelman,Toru Mukohara,et al.

2006457 citations

Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins

William W. Lockwood,Kreshnik Zejnullahu,et al.

2012344 citations

Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor

Dalia Ercan,Kreshnik Zejnullahu,et al.

2010227 citations

Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma

Arun M. Unni,William W. Lockwood,et al.

2015199 citations